SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-18-001210
Filing Date
2018-03-01
Accepted
2018-03-01 16:33:10
Documents
80
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2234132z10-k.htm 10-K 1517621
2 EX-23.1 a2234132zex-23_1.htm EX-23.1 3341
3 EX-31.1 a2234132zex-31_1.htm EX-31.1 7447
4 EX-31.2 a2234132zex-31_2.htm EX-31.2 7461
5 EX-32.1 a2234132zex-32_1.htm EX-32.1 4574
6 EX-32.2 a2234132zex-32_2.htm EX-32.2 4591
13 G509639.JPG g509639.jpg GRAPHIC 56717
14 G155778.JPG g155778.jpg GRAPHIC 44508
  Complete submission text file 0001047469-18-001210.txt   8448249

Data Files

Seq Description Document Type Size
7 EX-101.INS supn-20171231.xml EX-101.INS 2119194
8 EX-101.SCH supn-20171231.xsd EX-101.SCH 58360
9 EX-101.CAL supn-20171231_cal.xml EX-101.CAL 85784
10 EX-101.DEF supn-20171231_def.xml EX-101.DEF 208138
11 EX-101.LAB supn-20171231_lab.xml EX-101.LAB 607325
12 EX-101.PRE supn-20171231_pre.xml EX-101.PRE 405052
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 001-35518 | Film No.: 18657916
SIC: 2834 Pharmaceutical Preparations